IKT Inhibikase Therapeutics, Inc.

Fundamentals / CIK 0001750149 / USD

Inhibikase Therapeutics, Inc. reported $201.8M in total assets and a net loss of $69.17M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IKT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$8.15M$4.08M$0-$45.39MFY 2020 Revenue: $698KFY 2020 Net Income: -$2.85M2020FY 2021 Revenue: $3.10MFY 2021 Net Income: -$14.79M2021FY 2022 Revenue: $123KFY 2022 Net Income: -$18.05M2022FY 2023 Revenue: $261KFY 2023 Net Income: -$19.03M2023FY 2024 Revenue: $0FY 2024 Net Income: -$27.52M2024FY 2025 Net Income: -$48.26M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $0 $261K $123K $3.10M $698K
Research & Development $29.79M $17.21M $13.62M $12.03M $11.36M $894K
Selling, General & Admin $23.56M $11.38M $6.73M $6.22M $6.51M $2.62M
Operating Income -$51.97M -$28.59M -$20.09M -$18.13M -$14.77M -$2.82M
EBITDA -$51.91M -$28.56M -$19.91M -$18.12M -$14.77M --
Interest Expense -- -- -- -- $20K $29K
Income Before Tax -$48K -$28K -- -- -- --
Income Tax Expense $0 $0 -- -- -- --
Net Income -$48.26M -$27.52M -$19.03M -$18.05M -$14.79M -$2.85M
Basic EPS -$0.49 -$1.16 -$3.16 -$4.28 -$4.84 -$2.09
Diluted EPS -$0.49 -$1.16 -$3.16 -$4.28 -$4.84 -$2.09
Basic Shares Outstanding 98.3M 23.7M 6.0M 4.2M 3.1M 1.4M
Diluted Shares Outstanding 98.3M 23.7M 6.0M 4.2M 3.1M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- $0 $0 -- $0 $0 $0 $0
Research & Development $15.00M $13.39M $10.84M $6.36M $7.65M $5.27M $10.51M $7.19M
Selling, General & Admin $7.23M $7.66M $7.38M $6.77M $5.61M $5.92M $5.25M $5.74M
Operating Income -$22.23M -$21.05M -$17.84M -$13.78M -$12.77M -$10.83M -$14.60M -$12.93M
EBITDA -$22.23M -$21.05M -$17.84M -$13.78M -$12.74M -$10.81M -$14.59M -$12.92M
Income Tax Expense -- $0 $0 $0 $0 $0 $0 $0
Net Income -$20.47M -$19.59M -$16.38M -$12.73M -$11.93M -$9.92M -$13.68M -$12.13M
Basic EPS -$0.10 -$0.11 -$0.10 -- -$0.13 -$0.11 -$0.15 --
Diluted EPS -$0.10 -$0.11 -$0.10 -- -$0.13 -$0.11 -$0.15 --
Basic Shares Outstanding 196.9M 174.6M 172.3M -- 90.1M 90.0M 89.5M --
Diluted Shares Outstanding 196.9M 174.6M 172.3M -- 90.1M 90.0M 89.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $178.8M $97.50M $9.20M $7.19M $40.75M $13.95M
Short-Term Investments $39.54M $41.05M $4.09M $15.86M $0 --
Cash & Short-Term Investments $218.3M $138.6M $13.29M $23.05M $40.75M $13.95M
Total Current Assets $180.1M $98.45M $14.21M $24.37M $42.47M $14.78M
Property, Plant & Equipment, Net $0 $47K $73K $237K $0 --
Other Non-Current Assets $95K $0 -- -- -- --
Total Non-Current Assets $1.10M $149K $296K $565K $0 $0
Total Assets $181.2M $98.60M $14.51M $24.94M $42.47M $14.78M
Accounts Payable $1.16M $943K $647K $1.15M $1.09M $1.72M
Deferred Revenue (Current) -- -- -- -- $0 $2.33M
Total Current Liabilities $8.30M $3.73M $3.44M $3.70M $4.05M $4.72M
Long-Term Debt -- -- $382K -- $249K --
Total Non-Current Liabilities $0 $0 $90K $205K $0 $276K
Total Liabilities $8.30M $3.73M $3.53M $3.90M $4.05M $5.00M
Total Debt (incl. Leases) -- $111K $622K $351K $249K --
Common Stock $132K $69K $6.2K $4.2K $25K $10K
Retained Earnings -$142.7M -$94.42M -$66.90M -$47.87M -$29.82M $15.03M
Accumulated Other Comp. Income $22K -$37K $877 $105K $0 --
Total Stockholders' Equity $172.9M $94.87M $10.98M $21.04M $38.42M $9.78M
Total Equity $172.9M $94.87M $10.98M $21.04M $38.42M $9.78M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $51.70M $31.21M $49.57M $178.8M $38.27M $77.74M $73.44M $97.50M
Short-Term Investments $141.6M $127.8M $120.8M $39.54M $39.05M $9.92M $19.74M $41.05M
Cash & Short-Term Investments $193.3M $159.0M $170.4M $218.3M $77.32M $87.67M $93.18M $138.6M
Total Current Assets $198.7M $162.3M $172.2M $180.1M $78.54M $88.79M $94.16M $98.45M
Property, Plant & Equipment, Net -- -- -- $0 $0 $24K $48K $47K
Other Non-Current Assets $240K $245K $156K $95K $58K -- -- $0
Total Non-Current Assets $3.02M $1.24M $1.16M $1.10M $1.06M $59K $117K $149K
Total Assets $201.8M $163.6M $173.3M $181.2M $79.59M $88.85M $94.28M $98.60M
Accounts Payable $948K $992K $1.59M $1.16M $621K $2.70M $1.69M $943K
Total Current Liabilities $12.96M $10.26M $5.71M $8.30M $6.70M $8.80M $8.55M $3.73M
Other Non-Current Liabilities $400K $400K $400K -- -- -- -- --
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $12.96M $10.26M $5.71M $8.30M $6.70M $8.80M $8.55M $3.73M
Total Debt (incl. Leases) -- -- -- -- -- $38K $75K $111K
Common Stock $140K $132K $132K $132K $75K $75K $74K $69K
Retained Earnings -$199.1M -$178.7M -$159.1M -$142.7M -$129.9M -$118.0M -$108.1M -$94.42M
Accumulated Other Comp. Income -$109K -$73K -$26K $22K -$4.2K -$2.9K -$967 -$37K
Total Stockholders' Equity $188.8M $153.3M $167.6M $172.9M $72.90M $80.05M $85.73M $94.87M
Total Equity $188.8M $153.3M $167.6M $172.9M $72.90M $80.05M $85.73M $94.87M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$48.26M -$27.52M -$19.03M -$18.05M -$14.79M -$2.85M
Depreciation & Amortization $60K $26K $177K $6.7K $0 --
Stock-Based Compensation $15.31M $8.14M $500K $458K $1.53M $574K
Change in Receivables -- $0 $40K -$40K -$110K $0
Change in Payables $147K $272K -$504K $61K -$631K -$247K
Operating Cash Flow -$27.79M -$19.15M -$18.09M -$17.35M -$14.30M -$1.13M
Capital Expenditure -$13K $0 -$14K -$243K $0 --
Free Cash Flow -$27.80M -$19.15M -$18.10M -$17.59M -$14.30M --
Purchases of Investments -$39.09M -$60.46M -$29.43M -$20.73M $0 --
Investing Cash Flow $2.05M -$37.00M $11.66M -$16.01M $0 --
Common Stock Issued $107.6M $103.5M $8.54M $0 $0 $4.9K
Financing Cash Flow $108.5M $103.5M $8.41M -$205K $41.09M $15.06M
Net Change in Cash $82.73M $47.33M $1.98M -$33.56M $26.80M $13.94M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$20.47M -$19.59M -$16.38M -$12.73M -$11.93M -$9.92M -$13.68M -$12.13M
Depreciation & Amortization $0 $0 $0 $0 $24K $24K $13K $6.6K
Stock-Based Compensation $5.53M $5.35M $5.56M $4.53M $4.53M $4.21M $2.04M $7.91M
Change in Receivables -- -- -- -- -- -- -- $0
Change in Payables -$14K -$626K $429K $538K -$1.98M $912K $681K -$1.06M
Operating Cash Flow -$17.35M -$12.44M -$12.06M -$7.52M -$10.59M -$5.57M -$4.10M -$5.35M
Capital Expenditure $0 $0 $0 $0 $0 $0 -$13K $0
Free Cash Flow -$17.35M -$12.44M -$12.06M -$7.52M -$10.59M -$5.57M -$4.12M -$5.35M
Purchases of Investments -$75.69M -$55.03M -$90.58M -$99K -$39.00M $0 $0 -$50.11M
Investing Cash Flow -$12.61M -$5.91M -$80.48M -$99K -$28.75M $9.84M $21.05M -$38.76M
Common Stock Issued $49.11M $0 $2.90M $107.6M $0 $150 $0 $99.68M
Financing Cash Flow $50.46M -$14K $2.90M $108.6M -$134K $32K $0 $99.68M
Net Change in Cash $20.49M -$18.37M -$89.65M $101.0M -$39.47M $4.30M $16.95M $55.58M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -7712.0% -14686.2% -476.2% -403.5%
Net Profit Margin -- -- -7304.7% -14625.9% -476.9% -407.7%
Return on Equity (ROE) -27.9% -29.0% -173.3% -85.8% -38.5% -29.1%
Return on Assets (ROA) -26.6% -27.9% -131.2% -72.4% -34.8% -19.3%
Current Ratio 21.70x 26.37x 4.13x 6.59x 10.47x 3.13x
Quick Ratio 26.30x 37.11x 3.86x 6.24x 10.05x 2.96x
Debt to Equity -- 0.00x 0.06x 0.02x 0.01x --
Revenue Growth (YoY) -- -100.0% +111.0% -96.0% +343.9% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -36.6% -39.5% -30.4% -27.9% -65.4% -51.8% -42.6% -29.0%
Return on Assets (ROA) -34.3% -37.1% -29.4% -26.6% -59.9% -46.7% -38.8% -27.9%
Current Ratio 15.34x 15.82x 30.14x 21.70x 11.73x 10.09x 11.01x 26.37x
Quick Ratio 14.92x 15.50x 29.83x 26.30x 11.55x 9.96x 10.90x 37.11x
Debt to Equity -- -- -- -- -- 0.00x 0.00x 0.00x
Revenue Growth (YoY) -- -- -- -- -- -- -- -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0001750149) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:43 UTC · Open in terminal